Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA

NCT05334576 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

OTHER: Crizanlizumab

Sponsor

Andria Ford

Collaborators

[object Object]